Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)
针对罕见肿瘤的双重抗 CTLA-4 和抗 PD-1 阻断疗法的 II 期试验 SWOG/NCI 经验：肺浸润性粘液性或非粘液性鳞状腺癌（以前称为细支气管肺泡癌）
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359241293401
Chae, Young Kwang; Othus, Megan; Patel, Sandip Pravin; Gerber, David E; Tanvetyanon, Tawee; Kim, Hye Sung; Chung, Liam Il-Young; McLeod, Christine M; Lopez, Gabby; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Cristopher W; Blanke, Charles D; Kurzrock, Razelle
